Moxetumomab
Product Specifications
CAS Number
1622075-65-3
Target
Immunology/Inflammation related|||ADC Antibody
Related Pathways
Antibody-drug Conjugate/ADC Related|||Immunology/Inflammation
Purity
0.978
Bioactivity
Moxetumomab is a monoclonal antibody targeting CD22, which can be used to synthesise the antibody-drug conjugate (ADC) Moxetumomab pasudotox for the study of hairy cell leukaemia (HCL) .
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
032436-APC 200 µL
BAZ1B, NT (BAZ1B, WBSC10, WBSCR10, WBSCR9, WSTF, Tyrosine-protein kinase BAZ1B, Bromodomain adjacent to zinc finger domain protein 1B, Williams syndrome transcription factor, Williams-Beuren syndrome chromosomal region 10 protein, Williams-Beuren syndrome chromosomal region 9 protein, hWALp2) (APC) discontinued
Ask
View Details 